Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Quantum Biopharma ( (TSE:QNTM) ) just unveiled an update.
On October 8, 2025, Quantum BioPharma announced a whistleblower reward program offering up to USD $7 million for information leading to a successful outcome in their USD $700 million lawsuit against financial institutions accused of manipulating the company’s stock. This initiative is part of their efforts to hold perpetrators accountable and restore market integrity, highlighting the company’s proactive stance in addressing alleged stock manipulation that significantly impacted its share price and stakeholders.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative biotech solutions for treating neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company is engaged in the research and development of drug candidates at various stages and holds a significant stake in Unbuzzd Wellness Inc., which markets an OTC product developed by Quantum BioPharma.
Average Trading Volume: 3,611
Technical Sentiment Signal: Buy
Current Market Cap: C$94.44M
For a thorough assessment of QNTM stock, go to TipRanks’ Stock Analysis page.